Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $13.22

0.20 (-1.49%)

POWR Rating

Component Grades

Buy & Hold

C

Peer

D

Add CNCR to Watchlist
Sign Up

Category: Health & Biotech ETFs

Category

D

Ranked

#31 of 42

in category

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $13.22 52-week high $17.96
Prev. close $13.42 52-week low $10.41
Day low $13.09 Volume 7,791
Day high $13.41 Avg. volume 14,990
50-day MA $14.91 Dividend yield N/A
200-day MA $15.06

CNCR Stock Price Chart Interactive Chart >


Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio


The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

CNCR ETF Info

Issuer Range ETFs
Expense Ratio 0.79%
Underlying Index Range Cancer Therapeutics Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 10.97M
Net Asset Value (NAV) $13.22
Options? Yes
Total Holdings N/A

CNCR Top Holdings

Symbol Company % of Total
%
%
%
%
%
%
%
%
%
%

CNCR Price Returns

1-mo -13.14%
3-mo -11.75%
6-mo -9.51%
1-year 25.96%
3-year -48.91%
5-year -35.23%
YTD -1.86%
2023 -1.89%
2022 -42.31%
2021 -19.24%
2020 36.53%
2019 24.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!